Intervention Study Focused on the Intestinal Microbiome to Evaluate the Impact of a Wild Thyme Extract (Thymus Serpyllum) Extract With Anti-inflammatory and Metabolic Properties Against Functional Gastrointestinal Disorders.

Launched by FUNDACIÓN PÚBLICA ANDALUZA PARA LA INVESTIGACIÓN BIOMÉDICA ANDALUCÍA ORIENTAL · Oct 11, 2024

Keywords

ClinConnect Summary

Functional gastrointestinal disorders (FGD), recently referred to as disorders of gut-brain interactions (DGBI), are characterized by the presence of gastrointestinal symptoms related to abnormalities in motility, visceral sensitivity, intestinal permeability, immune activation, neuroendocrine function, central nervous system processing, and gut microbiota. The spectrum of symptoms occurring in these FGDs includes abdominal pain, diarrhea, constipation, bloating, a sense of fullness, nausea, and vomiting, and are associated with conditions such as irritable bowel syndrome (IBS), functional ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -Clinical diagnosis of functional gastrointestinal disorder.
• Exclusion Criteria:
• • Obesity.
• • Antibiotic treatment.
• • Pregnancy.
• • Clinical diagnoses of Inflammatory bowel disease.
• • Clinical diagnosis of Celiac disease
• • Clinical diagnosis of Hematological pathologies.
• • Clinical diagnosis of Autoimmune or immunodeficiency diseases.
• • Treatments with opioids, prokinetics, laxatives, antispasmodics, NSAIDs and proton pump inhibitors (PPIs).